Alajati, Abdullah <br/><br/>
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.  [electronic resource] 

 -  The Journal of clinical investigation  05 2020 
 - 2435-2450 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI131133  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Neoplasm--biosynthesis<br/>Benzamides<br/>Cell Adhesion Molecules--biosynthesis<br/>Cell Line, Tumor<br/>Drosophila melanogaster<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Liposomes<br/>MAP Kinase Signaling System<br/>Male<br/>Nitriles<br/>PTEN Phosphohydrolase--biosynthesis<br/>Phenylthiohydantoin--analogs & derivatives<br/>Prostatic Neoplasms--drug therapy<br/>Up-Regulation